ADTX
Aditxt Inc.
NASDAQ: ADTX · HEALTHCARE · BIOTECHNOLOGY
$0.22
-0.73% today
Updated 2026-04-29
Market cap
$196180.00
P/E ratio
—
P/S ratio
61.40x
EPS (TTM)
$-9,230.64
Dividend yield
—
52W range
$0 – $2,495
Volume
1.8M
Aditxt Inc. (ADTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,098,726.00%
ROE
-699.00%
ROA
-50.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-213000.00 | — | — | — |
| 2018 | $0.00 | $-5.69M | — | — | — |
| 2019 | $0.00 | $-5.83M | — | — | — |
| 2020 | $0.00 | $-9.15M | — | — | — |
| 2021 | $105034.00 | $-46.37M | 25.76% | -39,925.17% | -44,148.56% |
| 2022 | $933715.00 | $-27.65M | 17.88% | -2,728.88% | -2,961.29% |
| 2023 | $645176.00 | $-32.38M | -17.31% | -4,039.58% | -5,018.92% |
| 2024 | $133985.00 | $-34.45M | -367.95% | -20,796.36% | -25,708.85% |
| 2025 | $3.19M | $-43.10B | 8.39% | -612,542.22% | -1,349,028.20% |